Matches in Nanopublications for { ?s ?p "DDI between Pazopanib and Ivacaftor - Inhibits p-glycoprotein and affects heptatic metabolism via CYP3A4 therefore increases levels of pazopanib. Consider alternate therapy. [drugbank_resource:DB06589_DB08820]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.